|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:Good_Start_Genetics
gptkb:ArcherDX
gptkb:Ciitizen
gptkb:Clear_Genetics
gptkb:CombiMatrix
gptkb:Genelex
gptkb:Singular_Bio
gptkb:YouScript
Diploid
|
|
gptkbp:CEO
|
gptkb:Ken_Knight
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:focusesOn
|
precision medicine
rare diseases
cancer genetics
genetic information
hereditary disorders
|
|
gptkbp:founded
|
2010
|
|
gptkbp:founder
|
gptkb:Randy_Scott
|
|
gptkbp:headquartersLocation
|
gptkb:San_Francisco,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Invitae
|
|
gptkbp:industry
|
genetic testing
|
|
gptkbp:keyPerson
|
gptkb:Randy_Scott
gptkb:Katherine_Stueland
gptkb:Ken_Knight
gptkb:Lee_Bendekgey
gptkb:Robert_Nussbaum
gptkb:Sean_E._George
gptkb:Sean_George
gptkb:Shelly_Guyer
|
|
gptkbp:listedOn
|
gptkb:New_York_Stock_Exchange
|
|
gptkbp:mission
|
to bring comprehensive genetic information into mainstream medicine
|
|
gptkbp:notableProduct
|
prenatal screening
whole exome sequencing
carrier screening tests
genetic testing panels
hereditary cancer tests
pharmacogenomics tests
rare disease testing
|
|
gptkbp:numberOfEmployees
|
over 1,500
|
|
gptkbp:parentCompany
|
none
|
|
gptkbp:publiclyTraded
|
yes
|
|
gptkbp:S&P500Component
|
no
|
|
gptkbp:specializesIn
|
carrier screening
genetic diagnostics
hereditary disease testing
oncology genetic testing
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:NVTA
|
|
gptkbp:tradedOn
|
gptkb:NYSE:_NVTA
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.invitae.com/
|
|
gptkbp:bfsParent
|
gptkb:Alex_Furman
|
|
gptkbp:bfsLayer
|
5
|